Orlando Valdés Guerrero

Title: Orlando Valdés Guerrero: Innovator in Immunomodulation

Introduction

Orlando Valdés Guerrero is a notable inventor based in Havana, Cuba. He has made significant contributions to the field of immunology through his innovative research and development of pharmaceutical compositions. His work focuses on enhancing cancer treatment methodologies, particularly through the use of nanoparticles.

Latest Patents

Orlando Valdés Guerrero holds a patent for "Ganglioside GM3-containing nanoparticles as immunomodulators." This invention describes a pharmaceutical composition that includes conjugates of membrane vesicles and the GM3 ganglioside. The composition is characterized by its size, surface charge, and morphology, which are associated with nano-particulate systems. These properties provide advantageous effects as an immunomodulator, inducing a significant reduction of myeloid-derived suppressor cells. This reduction positively impacts lymphocyte response and improves the survival rates of patients with tumors. The patent also outlines the use of this composition in treating cancers with high levels of myeloid-derived suppressor cells, along with methods for selecting patients for this treatment.

Career Highlights

Orlando Valdés Guerrero is affiliated with the Centro de Inmunología Molecular, where he conducts his research and development activities. His work has been pivotal in advancing the understanding of immunomodulation and its applications in cancer therapy.

Collaborations

He has collaborated with notable colleagues, including Circe Mesa Pardillo and Liliana Oliver Ríos. Their combined efforts contribute to the ongoing research and development in the field of immunology.

Conclusion

Orlando Valdés Guerrero's innovative work in the development of GM3-containing nanoparticles represents a significant advancement in cancer treatment. His contributions to immunology continue to pave the way for new therapeutic strategies that can improve patient outcomes.